Pharmaids Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹4.34 crore and a net loss of ₹1.81 crore for the September 2026 quarter.
Pharmaids Pharma (BSE: PHARMAID) closed at ₹21.26 on 20 Nov 2026, down 54.4% over the past year. Its market capitalisation is ₹75 crore.
Incorporated in 1989, Pharmaids Pharmaceuticals Ltd operates in research, development, and manufacturing services. It is undergoing a business transition and aims to build a CRDMO platform.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.